美股异动|礼来盘前涨超1%,旗下重磅减肥药Zepbound帮助青少年减重

格隆汇
Nov 16
礼来(LLY.US)盘前涨超1%,报1459.17美元。消息面上,礼来公司的重磅肥胖症注射药物Zepbound在一项新研究中帮助12岁及以上的儿童安全减重,这为该制药公司打入年轻患者市场提供了助力。根据周日在“肥胖周”会议上公布的研究结果,这些患有肥胖症或超重,并伴有糖尿病前期和睡眠呼吸暂停等症状的青少年,在服药一年半后,身体质量指数(BMI)平均下降了约18.5%。这项包含160名患者、平均体重为240磅的试验发现,接受这种化学名为替尔泊肽药物治疗的患者,平均减重约40磅。(格隆汇)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10